{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T07:04:18Z","timestamp":1724483058040},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["UI-133612"],"award-info":[{"award-number":["UI-133612"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.vaccine.2013.11.014","type":"journal-article","created":{"date-parts":[[2013,11,17]],"date-time":"2013-11-17T05:15:21Z","timestamp":1384665321000},"page":"238-245","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunologic characterization of a novel inactivated nasal mumps virus vaccine adjuvanted with Protollin"],"prefix":"10.1016","volume":"32","author":[{"given":"Katie R.","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sazini","family":"Nzula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Burt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.11.014_bib0005","series-title":"Countries using Mumps vaccine in national immunization schedule 2011","year":"2011"},{"key":"10.1016\/j.vaccine.2013.11.014_bib0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-4419-7185-2_14","article-title":"Mumps is back: why is mumps eradication not working?","volume":"697","author":"MacDonald","year":"2011","journal-title":"Adv Exp Med Biol"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2013.11.014_bib0015","first-page":"51","article-title":"Mumps virus vaccines","volume":"82","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2013.11.014_bib0020","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.jocn.2008.05.002","article-title":"Post-vaccination encephalomyelitis: literature review and illustrative case","volume":"15","author":"Huynh","year":"2008","journal-title":"J Clin Neurosci"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2013.11.014_bib0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1517\/17425247.4.5.459","article-title":"Needle-free vaccine delivery","volume":"4","author":"Kersten","year":"2007","journal-title":"Expert Opin Drug Deliv"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.11.014_bib0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.addr.2008.09.005","article-title":"Nanoparticles for nasal vaccination","volume":"61","author":"Csaba","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"issue":"February (11)","key":"10.1016\/j.vaccine.2013.11.014_bib0035","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.vaccine.2004.09.010","article-title":"A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice","volume":"23","author":"Chabot","year":"2005","journal-title":"Vaccine"},{"issue":"July (29)","key":"10.1016\/j.vaccine.2013.11.014_bib0040","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1016\/j.vaccine.2007.05.004","article-title":"Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB\/c mice against challenge without eosinophilia or enhanced pathology","volume":"25","author":"Cyr","year":"2007","journal-title":"Vaccine"},{"issue":"September (27\/28)","key":"10.1016\/j.vaccine.2013.11.014_bib0045","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1016\/j.vaccine.2004.03.035","article-title":"Protollin: a novel adjuvant for intranasal vaccines","volume":"22","author":"Jones","year":"2004","journal-title":"Vaccine"},{"issue":"July (29)","key":"10.1016\/j.vaccine.2013.11.014_bib0050","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1016\/j.vaccine.2007.05.029","article-title":"TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces","volume":"25","author":"Chabot","year":"2007","journal-title":"Vaccine"},{"issue":"April (16)","key":"10.1016\/j.vaccine.2013.11.014_bib0055","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1016\/j.vaccine.2007.01.037","article-title":"C57Bl\/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine","volume":"25","author":"Cyr","year":"2007","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.11.014_bib0060","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/IAI.63.6.2382-2386.1995","article-title":"Intranasal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection","volume":"63","author":"Mallett","year":"1995","journal-title":"Infect Immun"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2013.11.014_bib0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0003-2697(78)90260-9","article-title":"A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria","volume":"85","author":"Karkhanis","year":"1978","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2013.11.014_bib0070","series-title":"Encyclopedia of statistical sciences","article-title":"K\u00e4rber method","author":"Cornell","year":"1982"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2013.11.014_bib0075","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/JVI.58.1.220-222.1986","article-title":"Monoclonal antibodies against the fusion protein are protective in necrotizing mumps meningoencephalitis","volume":"58","author":"Love","year":"1986","journal-title":"J Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.11.014_bib0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1128\/IAI.35.1.179-186.1982","article-title":"Differentiation of mumps virus strains with monoclonal antibody to the HN glycoprotein","volume":"35","author":"Server","year":"1982","journal-title":"Infect Immun"},{"issue":"June (21\/22)","key":"10.1016\/j.vaccine.2013.11.014_bib0085","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/S0264-410X(03)00220-2","article-title":"Growth phase of orally administered Lactobacillus strains differentially affects IgG1\/IgG2a ratio for soluble antigens: implications for vaccine development","volume":"21","author":"Maassen","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.014_bib0090","series-title":"Vaccine adjuvants and delivery systems","first-page":"1","article-title":"Development of vaccine adjuvants: a historical perspective","author":"Ott","year":"2007"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2013.11.014_bib0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2005.12.003","article-title":"Needle-free vaccine delivery","volume":"58","author":"Giudice","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2013.11.014_bib0100","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2013.11.014_bib0105","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/sj.clpt.6100420","article-title":"Heterologous prime\u2013boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques","volume":"82","author":"Pasetti","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.11.014_bib0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nm.1894","article-title":"Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease","volume":"15","author":"Delgado","year":"2009","journal-title":"Nat Med"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2013.11.014_bib0115","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nm1456","article-title":"A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines","volume":"12","author":"Moghaddam","year":"2006","journal-title":"Nat Med"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2013.11.014_bib0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1203\/PDR.0b013e3180686ce0","article-title":"Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple","volume":"62","author":"Polack","year":"2007","journal-title":"Pediatr Res"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2013.11.014_bib0125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.vaccine.2008.10.073","article-title":"TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model","volume":"27","author":"Cyr","year":"2009","journal-title":"Vaccine"},{"issue":"November (1)","key":"10.1016\/j.vaccine.2013.11.014_bib0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/viro.2000.0605","article-title":"Intranasal immunization with mumps virus DNA vaccine delivered by influenza virosomes elicits mucosal and systemic immunity","volume":"277","author":"Cusi","year":"2000","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2013.11.014_bib0135","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/088282402760312331","article-title":"Neutralizing B cell response in measles","volume":"15","author":"Bouche","year":"2002","journal-title":"Viral Immunol"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2013.11.014_bib0140","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1128\/CDLI.7.6.964-966.2000","article-title":"Evaluation of antibodies against a rubella virus neutralizing domain for determination of immune status","volume":"7","author":"Cordoba","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.11.014_bib0145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/JCM.21.3.449-451.1985","article-title":"Antibody response to individual rubella virus proteins in congenital and other rubella virus infections","volume":"21","author":"Katow","year":"1985","journal-title":"J Clin Microbiol"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2013.11.014_bib0150","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/infdis\/152.6.1219","article-title":"Glycoproteins of human parainfluenza virus type 3: characterization and evaluation as a subunit vaccine","volume":"152","author":"Ray","year":"1985","journal-title":"J Infect Dis"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2013.11.014_bib0155","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1128\/JVI.61.11.3416-3423.1987","article-title":"Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity","volume":"61","author":"Spriggs","year":"1987","journal-title":"J Virol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.11.014_bib0160","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/infdis\/155.6.1198","article-title":"Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection","volume":"155","author":"Walsh","year":"1987","journal-title":"J Infect Dis"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2013.11.014_bib0165","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/JVI.62.11.4232-4238.1988","article-title":"Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies","volume":"62","author":"Anderson","year":"1988","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13015314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13015314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T03:37:06Z","timestamp":1596857826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13015314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0264410X13015314"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunologic characterization of a novel inactivated nasal mumps virus vaccine adjuvanted with Protollin","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}